Related Experiment Video
Updated: Aug 11, 2026

10:41
Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
[Rapid-onset dystonia-parkinsonism]
1Zakład Genetyki, Instytut Psychiatrii i Neurologii, Warszawa. zaremba@ipin.edu.pl
Summary
Rapid-onset dystonia-parkinsonism (RDP, DYT12) is a genetic dystonia linked to the ATP1A3 gene mutation. This autosomal dominant condition causes abrupt neurological disability, often in the second decade of life.
Area of Science:
- Genetics
- Neurology
- Molecular Biology
Context:
- Rapid-onset dystonia-parkinsonism (RDP, DYT12) is a rare, autosomal dominant genetic disorder.
- Characterized by abrupt onset, typically in the second decade, leading to significant neurological disability.
- Previous research linked RDP to chromosome 19q13, suggesting a specific genetic locus.
Purpose:
- To identify the genetic basis of Rapid-onset dystonia-parkinsonism (DYT12).
- To characterize the clinical presentation and inheritance patterns of RDP.
- To investigate the role of the identified gene in the pathogenesis of dystonia.
Summary:
- RDP (DYT12) is an autosomal dominant dystonia linked to mutations in the NA+/K(+)-ATPase alpha3 subunit gene (ATP1A3).
- The condition presents with rapid onset, often in adolescence, and leads to severe, stationary neurological impairment.
- Haplotype analysis previously localized the RDP gene to chromosome 19q13.
Impact:
- Identifies ATP1A3 as the causative gene for RDP (DYT12), advancing understanding of dystonia genetics.
- Provides a molecular target for future research into RDP and related neurological disorders.
- Facilitates genetic counseling and potential therapeutic strategies for affected families.
Related Concept Videos
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Alterations in Muscle Tone ll
Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

